חובות לטווח קצר של החברה: Accuray (ARAY)

Accuray Incorporated (ARAY) maintains an impeccable reputation as the creator of CyberKnife systems, enjoying global recognition within the medical community. The business relies on providing cutting-edge oncology therapy services and patient support. Management is implementing high-precision developments to accelerate clinical procedures. This price chart on GURU.Markets reflects the asset's dynamics, where the current figure stands at 0.02, confirming the company's status in the sector.

The complex logistics of Accuray Incorporated (ARAY) radiation therapy systems require significant working capital to maintain supply chains. This metric aggregates all credit obligations with maturities of up to one year. Rising debt amid stable cash flow confirms growth, yet excessive debt threatens a liquidity gap. It is critical for investors to benchmark these amounts against operating revenue. Constant monitoring of short-term liabilities allows for a timely assessment of default risk.